ANIP
Price
$71.53
Change
+$0.71 (+1.00%)
Updated
May 8 closing price
Capitalization
1.43B
Earnings call today
ELAN
Price
$12.28
Change
+$0.27 (+2.25%)
Updated
May 8 closing price
Capitalization
7.87B
94 days until earnings call
Ad is loading...

ANIP vs ELAN

Header iconANIP vs ELAN Comparison
Open Charts ANIP vs ELANBanner chart's image
ANI Pharmaceuticals
Price$71.53
Change+$0.71 (+1.00%)
Volume$470.38K
Capitalization1.43B
Elanco Animal Health
Price$12.28
Change+$0.27 (+2.25%)
Volume$9.69M
Capitalization7.87B
ANIP vs ELAN Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. ELAN commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and ELAN is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ANIP: $71.53 vs. ELAN: $12.28)
Brand notoriety: ANIP: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 117% vs. ELAN: 178%
Market capitalization -- ANIP: $1.43B vs. ELAN: $7.87B
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. ELAN’s [@Pharmaceuticals: Other] market capitalization is $7.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, ANIP is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while ELAN’s TA Score has 5 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 5 bearish.
  • ELAN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than ANIP.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а +1.19% price change this week, while ELAN (@Pharmaceuticals: Other) price change was +29.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.21%. For the same industry, the average monthly price growth was +11.99%, and the average quarterly price growth was +4.71%.

Reported Earning Dates

ANIP is expected to report earnings on Aug 06, 2025.

ELAN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than ANIP($1.43B). ANIP YTD gains are higher at: 29.396 vs. ELAN (1.404). ANIP has higher annual earnings (EBITDA): 107M vs. ELAN (-224M). ELAN has more cash in the bank: 352M vs. ANIP (221M). ANIP has less debt than ELAN: ANIP (286M) vs ELAN (5.77B). ELAN has higher revenues than ANIP: ELAN (4.42B) vs ANIP (487M).
ANIPELANANIP / ELAN
Capitalization1.43B7.87B18%
EBITDA107M-224M-48%
Gain YTD29.3961.4042,094%
P/E Ratio79.85N/A-
Revenue487M4.42B11%
Total Cash221M352M63%
Total Debt286M5.77B5%
FUNDAMENTALS RATINGS
ANIP vs ELAN: Fundamental Ratings
ANIP
ELAN
OUTLOOK RATING
1..100
1924
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
47100
SMR RATING
1..100
9182
PRICE GROWTH RATING
1..100
4444
P/E GROWTH RATING
1..100
9397
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELAN's Valuation (88) in the Agricultural Commodities Or Milling industry is in the same range as ANIP (93) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that ANIP’s stock grew somewhat faster than ELAN’s over the last 12 months.

ELAN's SMR Rating (82) in the Agricultural Commodities Or Milling industry is in the same range as ANIP (91) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to ANIP’s over the last 12 months.

ELAN's Price Growth Rating (44) in the Agricultural Commodities Or Milling industry is in the same range as ANIP (44) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's P/E Growth Rating (93) in the Pharmaceuticals Other industry is in the same range as ELAN (97) in the Agricultural Commodities Or Milling industry. This means that ANIP’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPELAN
RSI
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
53%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WFH61.800.93
+1.53%
Direxion Work From Home ETF
DMA8.460.05
+0.59%
Destra Multi-Alternative Fund
HEFA36.810.16
+0.44%
iShares Currency Hedged MSCI EAFE ETF
SFLR31.720.09
+0.28%
Innovator Equity Managed Floor ETF
RLTY15.13-0.01
-0.07%
Cohen & Steers Real Estate Opportunities and Income Fund

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with SNDL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+2.25%
SNDL - ELAN
39%
Loosely correlated
+0.77%
VTRS - ELAN
36%
Loosely correlated
+5.70%
ACET - ELAN
33%
Poorly correlated
-2.45%
PAHC - ELAN
32%
Poorly correlated
+14.75%
TEVA - ELAN
32%
Poorly correlated
+2.67%
More